Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double‐blind placebo‐controlled 102‐week trial

J. Bailey, Clifford; C. Morales Villegas, Enrique; Woo, Vincent; Tang, Weihua; Ptaszynska, Agata; F. List, James

doi:10.1111/dme.12624

Public

Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double‐blind placebo‐controlled 102‐week trial

Published in Diabetic Medicine • Nov 8, 2014

Authors:

Clifford J. Bailey

Enrique C. Morales Villegas

Vincent Woo

Abstract

AIMS: To assess initial pharmacotherapy of Type 2 diabetes with the sodium-glucose cotransporter-2 inhibitor dapagliflozin. METHODS: This double-blind, placebo-controlled trial, randomly allocated people with Type 2 diabetes aged 18-77 years and inadequate glycaemic control on diet and exercise [HbA...

Subject

Dapagliflozin

Medicine

Metformin

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!